XML 27 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Cash and cash equivalents    
Restricted cash $ 544 $ 525
Securities purchased under resale agreements 318 463
Premises and equipment, accumulated depreciation 9,850 8,602
Other assets, reserves for credit losses 22 25
Liabilities    
Outstanding balance $ 42,573 $ 38,675
Shareholders’ Equity    
Preferred shares, par value (in dollars per share) $ 1.667 $ 1.667
Preferred shares, authorized (in shares) 20,000,000 20,000,000
Preferred shares, outstanding (in shares) 1,600 1,600
Preferred shares, issued (in shares) 1,600 1,600
Common shares, par value (in dollars per share) $ 0.20 $ 0.20
Common shares, authorized (in shares) 3,600,000,000 3,600,000,000
Common shares, issued (in shares) 743,000,000 761,000,000
Common shares, outstanding (in shares) 743,000,000 761,000,000
Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross $ 57,613 $ 53,645
Financing receivables, reserves for credit losses 229 64
Card Member loans    
Cash and cash equivalents    
Financing receivables, gross 107,964 88,562
Financing receivables, reserves for credit losses 3,747 3,305
Other    
Cash and cash equivalents    
Financing receivables, reserves for credit losses 59 52
Variable Interest Entity, Primary Beneficiary    
Cash and cash equivalents    
Restricted cash 5 11
Restricted investments 54 32
Liabilities    
Outstanding balance 12,662 13,803
Variable Interest Entity, Primary Beneficiary | Card Member receivables    
Cash and cash equivalents    
Financing receivables, gross 5,193 5,175
Variable Interest Entity, Primary Beneficiary | Card Member loans    
Cash and cash equivalents    
Financing receivables, gross $ 28,461 $ 26,587